Atb Cap Markets upgraded shares of Cresco Labs (OTCMKTS:CRLBF – Free Report) from a hold rating to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports.
Several other research analysts also recently commented on the company. Zacks Research raised Cresco Labs from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 12th. ATB Capital upgraded Cresco Labs to an “outperform” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy”.
View Our Latest Stock Analysis on Cresco Labs
Cresco Labs Stock Performance
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last issued its quarterly earnings data on Friday, November 7th. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). Cresco Labs had a negative return on equity of 14.25% and a negative net margin of 7.79%.The firm had revenue of $165.00 million for the quarter, compared to the consensus estimate of $163.74 million. On average, equities analysts forecast that Cresco Labs will post -0.2 earnings per share for the current fiscal year.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Read More
- Five stocks we like better than Cresco Labs
- How to Effectively Use the MarketBeat Ratings Screener
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- Consumer Staples Stocks, Explained
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- EV Stocks and How to Profit from Them
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
